Exposure cohort | Time interval | Outcome | ORLS (1963–1998) | England (1999–2011) |
---|
O | E | RR (95% CI) |
pvalue | O | E | RR (95% CI) |
pvalue |
---|
Multiple sclerosis | <1 year | Epilepsy | 13 | 3.6 | 3.6 (1.92–6.23) | <0.001 | 574 | 370.0 | 1.6 (1.44–1.70) | <0.001 |
1–4 years | 16 | 4.3 | 3.7 (2.12–6.08) | <0.001 | 1194 | 251.0 | 4.9 (4.66–5.24) | <0.001 |
5–9 years | 14 | 3.2 | 4.4 (2.41–7.48) | <0.001 | 726 | 166.0 | 4.5 (4.20–4.88) | <0.001 |
10+ years | 19 | 4.1 | 4.7 (2.80–7.34) | <0.001 | 86 | 22.8 | 3.9 (3.11–4.85) | <0.001 |
Total | 62 | 15.3 | 4.1 (3.14–5.27) | <0.001 | 2580 | 809.7 | 3.3 (3.14–3.40) | <0.001 |
Epilepsy | <1 year | Multiple sclerosis | 9 | 3.3 | 2.9 (1.29–5.67) | 0.003 | 206 | 196.1 | 1.1 (0.91–1.21) | 0.48 |
1–4 years | 9 | 3.4 | 2.7 (1.21–5.23) | 0.006 | 394 | 154.0 | 2.8 (2.52–3.13) | <0.001 |
5–9 years | 6 | 2.7 | 2.3 (0.82–5.09) | 0.083 | 206 | 90.5 | 2.4 (2.10–2.83) | <0.001 |
10+ years | 9 | 4.2 | 2.2 (0.99–4.24) | 0.034 | 19 | 9.9 | 2.0 (1.19–3.27) | <0.005 |
| Total | | 33 | 13.6 | 2.5 (1.71–3.54) | 0.001 | 825 | 450.4 | 1.9 (1.79–2.07) | <0.001 |
-
aAll analyses were undertaken initially within five-year age groups (and within the other strata used), using the combined MS and control cohorts (or the combined epilepsy and control cohorts) as the ‘standard’, to provide observed and expected numbers within (1) the MS cohort (or epilepsy cohort) and (2) the control cohort, within each stratum group. The stratum-specific observed and expected numbers in each cohort were then summed to give an age-standardised all-ages total, adjusted for age in 5-year bands, time period in single calendar years, region of residence and deprivation score associated with patients’ area of residence, in quintiles.
-
bConditions used in control cohort, with Office of Population, Censuses and Surveys (OPCS) code edition 4 for operations and ICD10 code for diagnosis (with equivalent codes used for other coding editions): adenoidectomy (OPCS4 E20), tonsillectomy (F34, F36), appendectomy (H01–H03), dilation and curettage (Q10–Q11), hip replacement (W37–W39), knee replacement (W40–W42), squint (ICD10 H49–H51), cataract (H25), otitis (H60–H67), varicose veins (I83), haemorrhoids (I84), upper respiratory tract infections (J00–J06), deflected septum, nasal polyp (J33+J34.2), impacted tooth and other disorders of teeth (K00–K03), inguinal hernia (K40), in-growing nail, toenail and other diseases of nail (L60), bunion (M20.1), internal derangement of knee (M23), contraceptive management (Z30).